ArticleFrontiers in pharmacology2023

Adverse events in patients with advanced urothelial carcinoma treated with erdafitinib: a retrospective pharmacovigilance study.

Tengfei Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.